Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies

NCT00741455 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancies

Interventions

PROCEDURE: Stem Cell Transplant
DRUG: G-CSF
DRUG: Fludarabine
DRUG: cyclophosphamide
DRUG: Cyclosporine
DRUG: Methotrexate

Sponsor

Dartmouth-Hitchcock Medical Center